Table 2.
Comparison of demographic and clinical characteristics and laboratory findings on ED arrival among NF patients with different levels of serum albumin.
| Admission Serum Albumin, g/dL | <2.5 | 2.5–3.0 | 3.0–3.5 | 3.5–4.0 | >4.0 | p-Value |
|---|---|---|---|---|---|---|
| n | 95 | 286 | 187 | 86 | 53 | |
| Age, years | 60.1 | 57.6 | 54.8 | 52.3 | 51.1 | <0.001 |
| (40.5–78.6) * | (42.3–70.8) * | (39.8–72.5) * | (43.7–78.1) * | (32.3–65.6) * | ||
| SBP at triage, mmHg | 141.2 | 137.5 | 132.9 | 133.7 | 132.5 | 0.58 |
| (121.4–167.9) * | (105.7–174.6) * | (111.2–164.7) * | (108.1–174.2) * | (109.6–178.5) * | ||
| DBP at triage, mmHg | 65.2 | 70.1 | 68.4 | 69.2 | 64.9 | 0.23 |
| (45.6–105.5) * | (55.8–101.6) * | (54.6–93.4) * | (49.5–94.8) * | (38.6–90.4) * | ||
| Episode of hypotension, n (%) | 25 (21.1%) # | 43 (18.5%) # | 32 (17.1%) # | 11 (12.6%) # | 6 (8.9%) # | <0.001 |
| SOFA score | 8 | 7 | 6 | 4 | 3 | <0.001 |
| (3–11) * | (2–8) * | (1–8) * | (0–7) * | (0–6) * | ||
| Hypothermia (BT < 36), n (%) | 12 (12.5%) # | 33 (15.4%) # | 26 (13.8%) # | 12 (14.2%) # | 8 (11.5%) # | 0.43 |
| hyperthermia (BT ≥ 38), n (%) | 27 (28.6%) # | 73 (25.6%) # | 42 (22.3%) # | 21 (24.9%) # | 11 (20.5%) # | 0.56 |
| Acidosis, n (%) | 34 (35.6%) # | 59 (20.5%) # | 33 (17.8%) # | 13 (15.6%) # | 3 (6.5%) # | <0.001 |
| Coagulopathy, n (%) | 26 (27.1%) # | 61 (21.3%) # | 39 (20.6%) # | 16 (18.4%) # | 10 (18.3%) # | 0.12 |
| Thrombocytopenia, n (%) | 38 (40.3%) # | 93 (32.6%) # | 34 (18.3%) # | 14 (15.9%) # | 3 (6.3%) # | <0.001 |
| Anemia, n (%) | 24 (25.4%) # | 61 (21.2%) # | 37 (19.8%) # | 14 (16.8%) # | 8 (15.5%) # | 0.45 |
| Hypoxia, n (%) | 14 (15.2%) # | 35 (12.4%) # | 26 (13.9%) # | 9 (10.7%) # | 5 (9.5%) # | 0.28 |
| In-hospital mortality, n (%) | 17 (17.9%) # | 11 (3.8%) # | 7 (3.7%) # | 3 (3.5%) # | 2 (3.8%) # | <0.001 |
| Diabetes mellitus, n (%) | 32 (34.1%) # | 84 (29.7%) # | 58 (31.2%) # | 24 (28.3%) # | 12 (23.3%) # | 0.06 |
| Liver cirrhosis, n (%) | 39 (41.5%) # | 95 (33.2%) # | 57 (30.8%) # | 22 (25.4%) # | 6 (11.3%) # | <0.001 |
| Heart failure, n (%) | 17 (18.6%) # | 61 (21.3%) # | 29 (15.4%) # | 15 (17.8%) # | 6 (10.9%) # | 0.49 |
| Chronic kidney disease, n (%) | 32 (33.8%) # | 75 (26.1%) # | 46 (24.9%) # | 16 (18.4%) # | 5 (9.5%) # | 0.23 |
| blood lactate (mmol/L) | 4.1 | 3.8 | 3.6 | 3.2 | 2.7 | <0.001 |
| (2.9–5.6) * | (2.6–5.1) * | (2.3–4.5) * | (2.4–4.1) * | (1.5–3.9) * | ||
| serum creatinine (mg/dL) | 2.4 | 2.2 | 2.2 | 1.8 | 1.6 | 0.08 |
| (1.5–3.6) * | (1.6–3.3) * | (1.2–2.9) * | (1.3–2.8) * | (0.8–2.7) * | ||
| serum glucose (mg/dL) | 174 | 166 | 168 | 149 | 147 | 0.54 |
| (124–298) * | (126–254) * | (117–249) * | (115–224) * | (107–226) * | ||
| serum CRP (mg/dL) | 174 | 158 | 142 | 129 | 78 | <0.001 |
| (56–225) * | (39–203) * | (31–195) * | (28–174) * | (25–151) * |
* Values are median (interquartile range). # Numbers in parentheses denote percentages. BT, body temperature; CRP, C-reactive protein; DBP, diastolic blood pressure; SBP, systolic blood pressure; SOFA, sequential organ failure assessment.